Ignite Creation Date:
2024-05-06 @ 3:52 PM
Last Modification Date:
2024-10-26 @ 1:58 PM
Study NCT ID:
NCT04782193
Status:
RECRUITING
Last Update Posted:
2023-04-18
First Post:
2021-02-26
Brief Title:
a Clinical Research of CD19 and CD22 Targeted Prime CAR-T Cell in RelapsedRefractory B Cell Lymphoma
Sponsor:
Organization:
Chongqing Precision Biotech Co Ltd